Enalapril: Difference between revisions
David Canner (talk | contribs) New page: <applet load="" size="480" color="" frame="true" spin="on" Scene ="Ramipril/Rama/1" align="right" caption="Ramiprilat, the metabolite of Ramipril, also known as Altace"/> ===Better Know... |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<applet load="" size="480" color="" frame="true" spin="on" Scene ="Ramipril/Rama/1" align="right" caption="Ramiprilat, the metabolite of Ramipril, also known as Altace"/> | <applet load="" size="480" color="" frame="true" spin="on" Scene ="Ramipril/Rama/1" align="right" caption="Ramiprilat, the metabolite of Ramipril, also known as Altace"/> | ||
===Better Known as: | ===Better Known as: Vasotec=== | ||
* Marketed By: | * Marketed By: Merck & Co.<br /> | ||
* Major Indication: Hypertension & Congestive Heart Failure<br /> | * Major Indication: Hypertension & Congestive Heart Failure<br /> | ||
* Drug Class: [[ACE]] Inhibitor | * Drug Class: [[ACE]] Inhibitor | ||
* Date of FDA Approval (Patent Expiration): | * Date of FDA Approval (Patent Expiration): 1985 (2000)<br /> | ||
* 2006 Sales: $650 Million | * 2006 Sales: $650 Million | ||
* Why You Should Care: One of the best selling [[Angiotensin-Converting Enzyme]] Inhibitors of all time. | * Why You Should Care: One of the best selling [[Angiotensin-Converting Enzyme]] Inhibitors of all time. | ||